Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States.
Adv Ther. 2023 Mar;40(3):1153-1170. doi: 10.1007/s12325-022-02365-1. Epub 2023 Jan 17.
Adv Ther. 2023.
PMID: 36648737
Free PMC article.
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores.
Riecke K, Müller V, Weide R, Schmidt M, Park-Simon TW, Möbus V, Mundhenke C, Polasik A, Lübbe K, Hesse T, Laakmann E, Thill M, A Fasching P, Denkert C, Fehm T, Nekljudova V, Rey J, Loibl S, Witzel I.
Riecke K, et al. Among authors: a fasching p.
Cancers (Basel). 2021 Feb 17;13(4):844. doi: 10.3390/cancers13040844.
Cancers (Basel). 2021.
PMID: 33671376
Free PMC article.
Item in Clipboard
Cite
Cite